Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5764 participants
OBSERVATIONAL
2002-01-01
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Levels and Survival in Cancer Patients
NCT03266887
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT01398202
Importance of Dosing Regimen for the Effect of Vitamin D Supplementation
NCT03272126
Seasonal Variations in Serum 25-hydroxy Vitamin-D Levels in a Swedish Cohort
NCT02136407
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors
NCT02750293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AGES-Reykjavik participants
Exploring whether pre-diagnostic serum levels of 25(OH)D among older individuals living in Iceland were associated with survival after cancer diagnosis. We also assessed the risk of being diagnosed with cancer in association with 25(OH)D levels.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
66 Years
98 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iceland
OTHER
Icelandic Heart Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johanna Torfadottir, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Iceland
References
Explore related publications, articles, or registry entries linked to this study.
Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007 May 1;165(9):1076-87. doi: 10.1093/aje/kwk115. Epub 2007 Mar 10.
Related Links
Access external resources that provide additional context or updates about the study.
Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied Phenomics
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NO1-AG-1-2100
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IHA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.